Login / Signup
Luspatercept mitigates bone loss driven by myelodysplastic neoplasms and estrogen-deficiency in mice.
Heike Weidner
Manja Wobus
Lorenz C Hofbauer
Martina Rauner
Uwe Platzbecker
Published in:
Leukemia (2022)
Keyphrases
</>
bone loss
acute myeloid leukemia
high fat diet induced
bone marrow
estrogen receptor
replacement therapy
insulin resistance
wild type